119 related articles for article (PubMed ID: 22413120)
21. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET.
Beckers C; Ribbens C; André B; Marcelis S; Kaye O; Mathy L; Kaiser MJ; Hustinx R; Foidart J; Malaise MG
J Nucl Med; 2004 Jun; 45(6):956-64. PubMed ID: 15181130
[TBL] [Abstract][Full Text] [Related]
22. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
[TBL] [Abstract][Full Text] [Related]
23. Impact of whole-body ¹⁸F-fluorodeoxyglucose positron emission tomography on therapeutic management of non-small cell lung cancer.
Heo EY; Yang SC; Yoo CG; Han SK; Shim YS; Kim YW
Respirology; 2010 Nov; 15(8):1174-8. PubMed ID: 20573060
[TBL] [Abstract][Full Text] [Related]
24. 18F-FDG PET and PET/CT in diagnosis and treatment monitoring of pyrexia of unknown origin due to tuberculosis with prominent hepatosplenic involvement.
Shejul Y; Chhajed PN; Basu S
J Nucl Med Technol; 2014 Sep; 42(3):235-7. PubMed ID: 24948823
[TBL] [Abstract][Full Text] [Related]
25. FDG PET for rheumatoid arthritis: basic considerations and whole-body PET/CT.
Kubota K; Ito K; Morooka M; Minamimoto R; Miyata Y; Yamashita H; Takahashi Y; Mimori A
Ann N Y Acad Sci; 2011 Jun; 1228():29-38. PubMed ID: 21718320
[TBL] [Abstract][Full Text] [Related]
26. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
27. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.
King AD; Ma BB; Yau YY; Zee B; Leung SF; Wong JK; Kam MK; Ahuja AT; Chan AT
Br J Radiol; 2008 Apr; 81(964):291-8. PubMed ID: 18344274
[TBL] [Abstract][Full Text] [Related]
28. Clinical impact of "true whole-body" (18)F-FDG PET/CT: lesion frequency and added benefit in distal lower extremities.
Kawata S; Imaizumi M; Kako Y; Oku N
Ann Nucl Med; 2014 May; 28(4):322-8. PubMed ID: 24488705
[TBL] [Abstract][Full Text] [Related]
29. Epitrochlear and axillary lymph node visualization on FDG-PET/CT imaging in a patient with rheumatoid arthritis.
Ozcan Kara P; Kaya B; Kara Gedik G; Sari O
Rev Esp Med Nucl; 2011; 30(3):168-70. PubMed ID: 20570414
[TBL] [Abstract][Full Text] [Related]
30. Fluorine-18-fluorodeoxyglucose uptake in rheumatoid arthritis-associated lung disease in a patient with thyroid cancer.
Bakheet SM; Powe J
J Nucl Med; 1998 Feb; 39(2):234-6. PubMed ID: 9476924
[TBL] [Abstract][Full Text] [Related]
31. Early detection of cancer recurrence: 18F-FDG PET/CT can make a difference in diagnosis and patient care.
Israel O; Kuten A
J Nucl Med; 2007 Jan; 48 Suppl 1():28S-35S. PubMed ID: 17204718
[TBL] [Abstract][Full Text] [Related]
32. F-18 FDG PET superscan.
Su HY; Liu RS; Liao SQ; Wang SJ
Clin Nucl Med; 2006 Jan; 31(1):28-9. PubMed ID: 16374120
[No Abstract] [Full Text] [Related]
33. [Update on the use of PET radiopharmaceuticals in inflammatory disease].
Martínez-Rodríguez I; Carril JM
Rev Esp Med Nucl Imagen Mol; 2013; 32(6):378-86. PubMed ID: 24028819
[TBL] [Abstract][Full Text] [Related]
34. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
Salem SS; Shahin MA
Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
[TBL] [Abstract][Full Text] [Related]
35. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
36. Multiple extra-articular synovial cysts complicated with rheumatoid arthritis.
Kirino Y; Ihata A; Shizukuishi K; Hama M; Takase K; Suda A; Ueda A; Ohno S; Takeno M; Ishigatsubo Y
Mod Rheumatol; 2009; 19(5):563-6. PubMed ID: 19526305
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of thyroid uptake on F18-fluorodeoxyglucose positron emission tomography.
Liu Y
Ann Nucl Med; 2009 Jan; 23(1):17-23. PubMed ID: 19205834
[TBL] [Abstract][Full Text] [Related]
38. [The use of ultrasound to assess the extent of inflammation in rheumatoid arthritis].
Hammer HB
Ultraschall Med; 2010 Aug; 31(4):437-8. PubMed ID: 20725899
[No Abstract] [Full Text] [Related]
39. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
40. Adult-onset Still disease: evaluation with serial f-18 fluorodeoxyglucose positron emission tomography.
Vranken E; Versijpt J; Winne L; Veys EM; Hamphrey H
Clin Nucl Med; 2005 Nov; 30(11):740-1. PubMed ID: 16237300
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
